RVL Pharmaceuticals
Bridgewater, US · Incorporated in Ireland
RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product. It serves consumers and healthcare providers with tech-enabled access and integrated fulfillment.
Founders & leadership
LD
Lori DeoChief Executive Officer
RD
Raymond DouglasHead of Scientific Affairs
AS
Amy ShahChief Growth Officer
KG
Katerina GembarskiChief Financial Officer
KC
Kristin ComerGeneral Counsel
JH
Jennifer HanlonChief Marketing Officer
JS
Jessica SolomonChief Human Resources Officer
PK
Patrick KaldawyChief Technology Officer
BM
BRIAN MARKISONNamed on SEC filing
GC
GREGORY COWANNamed on SEC filing
JV
JUAN VERGEZNamed on SEC filing
JB
JOAQUIN BENESNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2023
▶$5MraisedAug 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedAug 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- BRIAN MARKISONExecutive Officer, Director
- GREGORY COWANDirector
- JUAN VERGEZDirector
- JOAQUIN BENESDirector
- MICHAEL DEBIASIDirector
- ALISA LASKDirector
- JAMES SCHAUBExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $812.5K
- Placement agents
- H.C. WAINWRIGHT & CO., LLC
- First sale
- Aug 2023
- Incorporated
- Other, Ireland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does RVL Pharmaceuticals do?
- RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product. It serves consumers and healthcare providers with tech-enabled access and integrated fulfillment.
- How much funding has RVL Pharmaceuticals raised?
- RVL Pharmaceuticals has disclosed $5M raised across 1 round.
- Where is RVL Pharmaceuticals headquartered?
- RVL Pharmaceuticals is headquartered in Bridgewater, US.